2022年5月19日 · In 2017 a federal jury found Shkreli, dubbed "Pharma Bro" in the media, guilty on two counts of securities fraud and one count of conspiracy to commit securities fraud. He was sentenced to seven...

On December 17, 2015, Shkreli was arrested by the FBI after a federal indictment in the U.S. District Court for the Eastern District of New York was filed, charging him with securities fraud. The charges were filed after an investigation into his tenure at …

2018年3月9日 · He was convicted by a federal jury in August 2017, following a six-week trial, of two counts of securities fraud and one count of securities fraud conspiracy.

2015年12月18日 · Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents after being...

2018年3月9日 · NEW YORK — Martin Shkreli, the smirking “Pharma Bro” vilified for jacking up the price of a lifesaving drug, was sentenced Friday to seven years in prison for defrauding investors in two failed...

2022年5月18日 · Convicted “Pharma bro” Martin Shkreli was released from federal prison and into a halfway house Wednesday, less than five years into a seven-year sentence, his attorney said.

2020年1月28日 · Martin Shkreli (C), CEO of Turing Pharmaceutical, is brought out of 26 Federal Plaza by law enforcement officials after being arrested for securities fraud on December 17, 2015, in New York...

2015年12月17日 · Martin Shkreli (C), CEO of Turing Pharmaceutical, is brought out of 26 Federal Plaza by law enforcement officials after being arrested for securities fraud on December 17. Andrew Burton /...

Martin Shkreli, a former pharmaceutical investor convicted of securities fraud, has been released from prison after having served part of a seven-year sentence.

2024年1月23日 · Martin Shkreli's lifetime ban from the pharmaceutical industry was upheld by a federal appeals court in New York on Tuesday. A three-judge panel of the 2nd U.S. Circuit Court of Appeals ruled Shkreli was punished appropriately for antitrust violations.